Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1880943

CC(C)(S)CN.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL925414 0.96
SCHEMBL8411582 0.92
Hydrochloric Acid SCHEMBL6513703 0.88
Hydrochloric Acid SCHEMBL3896194 0.83
Ethylene Glycol SCHEMBL7596816 0.82 CYP2D6 (0.39)
SCHEMBL925703 0.78
SCHEMBL28807232 0.75
Hydrochloric Acid SCHEMBL20425030 0.74
Hydrochloric Acid SCHEMBL2188465 0.73
SCHEMBL10822964 0.73 NFKB1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 228 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129018-A1 PLEUROMUTILIN DERIVATIVES CONTAINING CYCLOALKYL GROUP AND PREPARATION METHODS AND APPLICATIONS THEREOF Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS (CN) 2025-04-24 US claimed
EP-3743270-B1 CAST-MOLDING PROCESS FOR PRODUCING UV-ABSORBING CONTACT LENSES ALCON INC (CH) 2022-06-08 EP claimed
EP-3917977-A1 HIGH MOLECULAR WEIGHT POLY(METHACRYLIC ACID) Alcon Inc. (CH) 2021-12-08 EP claimed
US-11111327-B2 Cast-molding process for producing UV-absorbing contact lenses ALCON INC. (CH) 2021-09-07 US claimed
US-11001652-B2 High molecular weight poly(methacrylic acid) ALCON INC. (CH) 2021-05-11 US claimed
EP-3743270-A1 CAST-MOLDING PROCESS FOR PRODUCING UV-ABSORBING CONTACT LENSES Alcon Inc. (CH) 2020-12-02 EP claimed
WO-2020157630-A1 HIGH MOLECULAR WEIGHT POLY(METHACRYLIC ACID) ALCON INC. (CH) 2020-08-06 WO claimed
US-20200239606-A1 HIGH MOLECULAR WEIGHT POLY(METHACRYLIC ACID) CIBA VISION GMBH (DE) 2020-07-30 US claimed
US-20190225726-A1 CAST-MOLDING PROCESS FOR PRODUCING UV-ABSORBING CONTACT LENSES ALCON INC. (CH) 2019-07-25 US claimed
US-6333110-B1 Functionalized nanocrystals as visual tissue-specific imaging agents, and methods for fluorescence imaging BIO-PIXELS LTD. 2001-12-25 US claimed
US-6114038-A Functionalized nanocrystals and their use in detection systems BIOCRYSTAL LTD. (US) 2000-09-05 US claimed
EP-4680605-A1 SUBSTITUTED PYRIDYL/PYRAZIDYL DIHYDROBENZOTHIAZEPINE COMPOUNDS FOR COMBATTING PHYTOPATHOGENIC FUNGI BASF SE (DE) 2026-01-21 EP disclosed
US-12503730-B2 Detectable nucleotide analogues THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2025-12-23 US disclosed
US-20250236911-A1 DESIGN AND SYNTHESIS OF NOVEL DISULFIDE LINKER BASED NUCLEOTIDES AS REVERSIBLE TERMINATORS FOR DNA SEQUENCING BY SYNTHESIS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2025-07-24 US disclosed
US-20250129018-A1 PLEUROMUTILIN DERIVATIVES CONTAINING CYCLOALKYL GROUP AND PREPARATION METHODS AND APPLICATIONS THEREOF Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS (CN) 2025-04-24 US disclosed
EP-0679084-A4 1995-11-08 EP disclosed
EP-0679084-A1 HYDANTOIN AND SUCCINIMIDE-SUBSTITUTED DERIVATIVES OF SPIROINDANYLCAMPHORSULFONYL OXYTOCIN ANTAGONISTS MERCK & CO. INC. (US) 1995-11-02 EP disclosed
EP-0673781-A1 Recording sheets containing amine salts and quaternary choline halides XEROX CORPORATION (US) 1995-09-27 EP disclosed
WO-1994014438-A1 HYDANTOIN AND SUCCINIMIDE-SUBSTITUTED DERIVATIVES OF SPIROINDANYLCAMPHORSULFONYL OXYTOCIN ANTAGONISTS MERCK & CO., INC. (US) 1994-07-07 WO disclosed
EP-0193389-A2 Use of a coupler comprising a coupler moiety having a releasable bleach accelerator moiety EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1986-09-03 EP disclosed